Alzinova (ALZ)

Last close As at 02/10/2025

SEK1.12

0.00 (−0.36%)

Market capitalisation

SEK118m

Alzinova is a Swedish biopharmaceutical company in clinical development specializing in the treatment of Alzheimer’s disease.

Latest Insights

Healthcare | Non client QV

Alzinova — Innovative new approach to Alzheimer’s

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Tord Labuda

    CEO

  • Erik Kullgren

    CFO

Thematics

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free